Close Menu

NEW YORK (GenomeWeb) – Bio-Rad Laboratories has announced a partnership with Genetic Analysis, an Oslo, Norway-based clinical diagnostics firm focusing on the microbiome.

Under the terms of the agreement, Bio-Rad will make an equity investment in Genetic Analysis. In return, it will receive commercialization rights in certain undisclosed territories for Genetic Analysis' CE-marked GA-map technology to detect microbial imbalances, also known as gut dysbiosis, the firms said in a statement.

Financial and other details were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Two researchers are calling for education for scientists on defending facts.

Researchers were among those who marched in London this weekend to call for another vote on Brexit.

Duke has agreed to pay $112.5 million to settle a lawsuit regarding its handling of data falsified by biologist Erin Potts-Kant. 

In PLOS this week: genetic factors influencing inorganic arsenic metabolism and toxicity, a germline variant in the cell adhesion molecule-coding gene DSCAM, and more.